Alabama Committee of Public Health Makes Anesthetic Drug Propofol a High Risk Controlled Substance

The Alabama State Committee of Public Health has classified anesthetic drug Propofol as a Schedule IV controlled substance, according to a state press release.

Advertisement

The list divides substances into five schedules with Schedule V being the highest risk. Schedule IV means hospitals must store the drugs securely and keep detailed records of who accesses the drugs and who administers and disposes of it.

The committee said it approved the scheduling because of Propofol’s “potential for misuse” while acknowledging it has an appropriate medical use for sedation.

The new classification begins Aug. 27.

More Articles on Anesthesia:
Anesthesia Medical Group Venture Raises $42M
Improving Perioperative Efficiency, Quality Requires Nursing-Anesthesia Partnership
Colorado Court Says CRNAs Can Administer Anesthesia

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.